Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) Gross Profit: 2009-2024

Historic Gross Profit for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $2.6 billion.

  • UNITED THERAPEUTICS's Gross Profit rose 4.93% to $698.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year increase of 13.29%. This contributed to the annual value of $2.6 billion for FY2024, which is 24.04% up from last year.
  • According to the latest figures from FY2024, UNITED THERAPEUTICS's Gross Profit is $2.6 billion, which was up 24.04% from $2.1 billion recorded in FY2023.
  • UNITED THERAPEUTICS's Gross Profit's 5-year high stood at $2.6 billion during FY2024, with a 5-year trough of $1.4 billion in FY2020.
  • Moreover, its 3-year median value for Gross Profit was $2.1 billion (2023), whereas its average is $2.1 billion.
  • Data for UNITED THERAPEUTICS's Gross Profit shows a peak YoY climbed of 24.04% (in 2024) over the last 5 years.
  • UNITED THERAPEUTICS's Gross Profit (Yearly) stood at $1.4 billion in 2020, then rose by 13.66% to $1.6 billion in 2021, then rose by 14.18% to $1.8 billion in 2022, then grew by 15.99% to $2.1 billion in 2023, then grew by 24.04% to $2.6 billion in 2024.